• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Biomet

Biomet

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. EU Approves $13 Billion Biomet -Zimmer Merger, Subject to Asset Sales

    EU Approves $13 Billion Biomet -Zimmer Merger, Subject to Asset Sales

  2. EU approves $13 billion Biomet -Zimmer merger

    EU approves $13 billion Biomet -Zimmer merger

  3. Investors Scoop Up Companies' Bonds

    Investors Scoop Up Companies' Bonds

  4. Research and Markets: MediPoint: Craniomaxillofacial Devices - 5EU Analysis and Market Forecasts

    Research and Markets: MediPoint: Craniomaxillofacial Devices - 5EU Analysis and Market Forecasts

  5. Research and Markets: China Dental Implant and Final Abutment Market Report 2015

    Research and Markets: China Dental Implant and Final Abutment Market Report 2015

  6. Research and Markets: Australia Orthopedic Devices Market Assessment and Forecasts To 2020

    Research and Markets: Australia Orthopedic Devices Market Assessment and Forecasts To 2020

  7. Research and Markets: Canada Orthopedic and Spine Market - Forecast and Trends Through 2019

    Research and Markets: Canada Orthopedic and Spine Market - Forecast and Trends Through 2019

  8. Tides Turn for These Orthopedic Firms

    Industry dynamics are shifting in the wake of Zimmer's Biomet acquisition.

  9. “Tax Reform is Impossible – Until it is Inevitable”

    Biomet moves closer to private territory.

  10. Gaining Perspective on Emerging Markets Fixed Income

    We still believe in Biomet , despite the transitions it faces.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.